Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,084 GBp
Change Today -6.00 / -0.55%
Volume 1.2M
SN/ On Other Exchanges
Symbol
Exchange
New York
OTC US
Frankfurt
Frankfurt
As of 11:35 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for smith & nephew plc (SN/)

Year over year, Smith & Nephew plc has seen their bottom line shrink from $556.0M USD to $501.0M USD despite an increase in revenues from $4.4B USD to $4.6B USD. An increase in the percentage of sales devoted to SGA costs from 49.39% to 50.31% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues4,270.04,137.04,351.04,617.0
TOTAL REVENUES4,270.04,137.04,351.04,617.0
Cost of Goods Sold1,133.01,067.01,083.01,127.0
GROSS PROFIT3,137.03,070.03,268.03,490.0
Selling General & Admin Expenses, Total2,059.01,982.02,149.02,323.0
R&D Expenses167.0171.0231.0235.0
OTHER OPERATING EXPENSES, TOTAL2,226.02,153.02,380.02,558.0
OPERATING INCOME911.0917.0888.0932.0
Interest Expense-12.0-9.0-10.0-35.0
Interest and Investment Income4.011.014.013.0
NET INTEREST EXPENSE-8.02.04.0-22.0
Income (Loss) on Equity Investments--4.0-1.0-2.0
Currency Exchange Gains (Loss)0.00.00.00.0
Other Non-Operating Income (Expenses)1.0-----1.0
EBT, EXCLUDING UNUSUAL ITEMS904.0923.0891.0907.0
Merger & Restructuring Charges-40.0-76.0-89.0-179.0
Impairment of Goodwill---6.0----
Gain (Loss) on Sale of Assets--251.0----
Other Unusual Items, Total-23.0-----14.0
Legal Settlements-23.0------
EBT, INCLUDING UNUSUAL ITEMS841.01,092.0802.0714.0
Income Tax Expense266.0371.0246.0213.0
Earnings from Continuing Operations575.0721.0556.0501.0
NET INCOME575.0721.0556.0501.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS575.0721.0556.0501.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS575.0721.0556.0501.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SN/:LN 1,084.00 GBp -6.00

SN/ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $171.30 USD -1.47
Edwards Lifesciences Corp $142.45 USD -1.15
Olympus Corp ¥4,400 JPY +105.00
St Jude Medical Inc $73.03 USD -0.60
Zimmer Biomet Holdings Inc $108.19 USD -1.02
View Industry Companies
 

Industry Analysis

SN/

Industry Average

Valuation SN/ Industry Range
Price/Earnings 30.3x
Price/Sales 3.3x
Price/Book 3.7x
Price/Cash Flow 30.1x
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITH & NEPHEW PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.